Haoqiang Ying

19.0k total citations · 5 hit papers
59 papers, 8.4k citations indexed

About

Haoqiang Ying is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Haoqiang Ying has authored 59 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 31 papers in Oncology and 22 papers in Cancer Research. Recurrent topics in Haoqiang Ying's work include Cancer-related Molecular Pathways (14 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Haoqiang Ying is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Haoqiang Ying collaborates with scholars based in United States, China and Germany. Haoqiang Ying's co-authors include Alec C. Kimmelman, Ronald A. DePinho, Xiaoxu Wang, Costas A. Lyssiotis, John M. Asara, Jayne M. Stommel, Lewis C. Cantley, Marcia C. Haigis, Nabeel Bardeesy and Lynda Chin and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Haoqiang Ying

59 papers receiving 8.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway

2013 1.5k citations Haoqiang Ying, Xiaoxu Wang et al. profile →
Pancreatic cancers require autophagy for tumor growth

2011 1.2k citations Shenghong Yang, Xiaoxu Wang et al. Genes & Development profile →
Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion

2016 813 citations Xiaoxu Wang, Haoqiang Ying et al. profile →
Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies

2007 699 citations Jayne M. Stommel, Alec C. Kimmelman et al. Science profile →
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation

2008 573 citations Hongwu Zheng, Haoqiang Ying et al. profile →

Peers

Haoqiang Ying

ONCOL

EPIDE

IMMUN

Julio A. Aguirre‐Ghiso United States

M. James You United States

Jayne M. Stommel United States

Lyuba Varticovski United States

Othon Iliopoulos United States

Stephanos Pavlides United States

Michael Ohh Canada

Seth J. Parker United States

Hiroaki Okuyama Japan

Antonio Di Cristofano United States

Julio A. Aguirre‐Ghiso United States

Haoqiang Ying

4.7k ×0.9

3.2k ×1.1

4.9k ×1.7

ONCOL

968 ×0.7

EPIDE

1.3k ×1.6

IMMUN

Citations per year, relative to Haoqiang Ying Haoqiang Ying (= 1×) peers Julio A. Aguirre‐Ghiso

Countries citing papers authored by Haoqiang Ying

Since Specialization

Citations

This map shows the geographic impact of Haoqiang Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoqiang Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoqiang Ying more than expected).

Fields of papers citing papers by Haoqiang Ying

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoqiang Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoqiang Ying. The network helps show where Haoqiang Ying may publish in the future.

Co-authorship network of co-authors of Haoqiang Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Haoqiang Ying. A scholar is included among the top collaborators of Haoqiang Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoqiang Ying. Haoqiang Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Denu, Ryan A., Ahsan Farooqi, Davis R. Ingram, et al.. (2024). Impact of ATRX loss on survival and immune microenvironment in multiple sarcoma subtypes.. Journal of Clinical Oncology. 42(16_suppl). 11511–11511. 2 indexed citations

Li, Fei, Inah Hwang, Libo Xu, et al.. (2023). Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenance. Nature Communications. 14(1). 1756–1756. 19 indexed citations

Liu, Yi, Yasunori Deguchi, Daoyan Wei, et al.. (2022). Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ. Nature Communications. 13(1). 2665–2665. 45 indexed citations

Zhao, Xixi, Yongkun Wei, Yu‐Yi Chu, et al.. (2022). Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function. Cancer Research. 82(11). 2185–2195. 36 indexed citations

Liang, Yan, Bo Tu, Jun Yao, et al.. (2021). Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition. Cancer Research. 81(15). 4054–4065. 30 indexed citations

Oh, Hwanhee, Inah Hwang, Lingxiang Wu, et al.. (2021). Therapy-Induced Transdifferentiation Promotes Glioma Growth Independent of EGFR Signaling. Cancer Research. 81(6). 1528–1539. 7 indexed citations

Han, Yan, Yeran Yang, Jun Yan, et al.. (2021). Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. Oncogene. 40(50). 6759–6771. 17 indexed citations

Deng, Yalan, Xianghou Xia, Yang Zhao, et al.. (2021). Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance. Nature Communications. 12(1). 7041–7041. 84 indexed citations

Xu, Bo, et al.. (2020). Upregulated lncRNA THRIL/TNF-α Signals Promote Cell Growth and Predict Poor Clinical Outcomes of Osteosarcoma. SHILAP Revista de lepidopterología. 1 indexed citations

10.

Yu, Meifang, Nicholas D. Nguyen, Yanqing Huang, et al.. (2019). Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. JCI Insight. 4(16). 129 indexed citations

11.

Li, Fei, Zhong Deng, Ling Zhang, et al.. (2019). ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization. The EMBO Journal. 38(19). e96659–e96659. 87 indexed citations

12.

Ju, Huai‐Qiang, Haoqiang Ying, Tian Tian, et al.. (2017). Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma. Nature Communications. 8(1). 14437–14437. 78 indexed citations

13.

Klingler, Stefan, Baofeng Guo, Jun Yao, et al.. (2015). Development of Resistance to EGFR-Targeted Therapy in Malignant Glioma Can Occur through EGFR-Dependent and -Independent Mechanisms. Cancer Research. 75(10). 2109–2119. 29 indexed citations

14.

Normolle, Daniel P., Douglas J. Hartman, Haoqiang Ying, et al.. (2014). Neuroplastic Changes Occur Early in the Development of Pancreatic Ductal Adenocarcinoma. Cancer Research. 74(6). 1718–1727. 143 indexed citations

15.

Du, Wei, Yong Yi, Haibo Zhang, et al.. (2013). Correction: Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy. PLoS ONE. 8(12). 4 indexed citations

16.

Liu, Yunhui, et al.. (2012). Action of db-cAMP on the bystander effect and chemosensitivity through connexin 43 and Bcl-2-mediated pathways in medulloblastoma cells. Oncology Reports. 28(3). 969–976. 9 indexed citations

17.

Yang, Shenghong, Xiaoxu Wang, Gianmarco Contino, et al.. (2011). Pancreatic cancers require autophagy for tumor growth. Genes & Development. 25(7). 717–729. 1163 indexed citations breakdown →

18.

Liu, Yunhui, Haoqiang Ying, Yixue Xue, et al.. (2010). Increasing of Blood-tumor Barrier Permeability through Paracellular Pathway by Low-frequency Ultrasound Irradiation In Vitro. Journal of Molecular Neuroscience. 43(3). 541–548. 23 indexed citations

19.

Stommel, Jayne M., Alec C. Kimmelman, Haoqiang Ying, et al.. (2007). Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies. Science. 318(5848). 287–290. 699 indexed citations breakdown →

20.

Sdek, Patima, Haoqiang Ying, Donny L.F. Chang, et al.. (2005). MDM2 Promotes Proteasome-Dependent Ubiquitin-Independent Degradation of Retinoblastoma Protein. Molecular Cell. 20(5). 699–708. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact